This is a routine CFO transition with an internal interim replacement already named, reducing near-term disruption risk. Monitor for the permanent CFO appointment announcement, which could signal strategic direction. No immediate trading catalyst from this filing alone.
Price Chart
Executive Summary
Pfizer announced that CFO Dave Denton will step down effective August 15, 2026 to pursue a consumer goods opportunity, with Senior VP Cecile Guegan appointed as Interim CFO effective August 16. The company explicitly states the departure is unrelated to financial or operating results. A comprehensive internal and external search for a permanent CFO is underway.
Key Facts
- CFO Dave Denton notified Pfizer on June 16, 2026 of his departure effective August 15, 2026 for a professional opportunity outside the pharmaceutical industry in consumer goods
- Cecile Guegan, SVP Finance, Global Biopharmaceutical Business, named Interim CFO effective August 16, 2026
- Departure stated as not related to the company's financial or operating results or any disagreements with accounting/reporting policies
- Pfizer will conduct a comprehensive internal and external search for a permanent CFO successor
Financial Impact
No financial figures disclosed in this filing; CFO transition with interim appointment — no immediate financial impact
Risk Factors
- Extended CFO vacancy could create leadership uncertainty if permanent search takes longer than expected
- Interim CFO may lack the external investor relations experience of the departing CFO, potentially affecting communication during the next earnings call
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000078003-26-000085 |
| Document: draftcfoannouncement061726.htm | 0000078003-26-000085 |
| Document: 0000078003-26-000085-index-headers.html | 0000078003-26-000085 |
| Document: 0000078003-26-000085-index.html | 0000078003-26-000085 |
| Document: 0000078003-26-000085.txt | 0000078003-26-000085 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 13, 2026 7w ago | Court Ruling | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.55 (+2.78%) |
Aug 12, 2026 7w ago | Insider Buy | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.55 (+2.78%) |
Aug 12, 2026 7w ago | Insider Cluster | $26.80 $27.72 | ▲ +3.43% | ▲ +5.18% | $27.55 (+2.78%) |
Aug 6, 2026 8w ago | Insider Cluster | $26.20 $28.81 | ▲ +9.95% | ▲ +9.35% | $27.55 (+5.13%) |
Aug 5, 2026 8w ago | Insider Cluster | $26.20 $28.81 | ▲ +9.95% | ▲ +9.35% | $27.55 (+5.13%) |
Aug 4, 2026 8w ago | 8-K | $25.41 $28.55 | ▲ +12.36% | ▲ +13.60% | $27.55 (+8.40%) |
Jul 31, 2026 9w ago | Court Ruling | $25.01 $27.96 | ▼ −11.80% | ▼ −8.81% | $27.55 (−10.14%) |
Jul 24, 2026 10w ago | Court Ruling | $24.54 $28.07 | ▲ +14.38% | ▲ +10.76% | $27.55 (+12.25%) |
Jul 6, 2026 12w ago | ANALYST-DOWNGRADE | $23.72 $25.01 | ▼ −5.44% | ▼ −6.00% | $27.55 (−16.13%) |
Jun 18, 2026 15w ago | 8-K | $25.21 $25.14 | ▼ −0.28% | ▼ −0.81% | $27.55 (+9.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access